NCT02113709

Brief Summary

Objective: To find out how much visual improvement is possible in severe amblyopia using full-time occlusion therapy with an eye patch and to see if improvement is influenced by the patient's age. Methods: An interventional clinical trial of 115 consecutive cases with unilateral, severe amblyopia was conducted at a tertiary referral center from Jan 2010 to Oct 2012. Patients were divided into three age groups: 3-7 years (n= 38), 8-12 years (n=41), 13-35 years (n=36). After a complete ophthalmological examination by a single ophthalmologist, cases with organic visual loss were excluded; cases with previous part-time occlusion therapy that had failed were included in the study. Patients were given optimal refractive correction for a month, followed by full-time occlusion therapy along with near visual activities for 3-4 hours/day. The therapy was continued until maximum visual recovery was achieved (6/6 Snellen's). Therapy was gradually reduced and stopped. Patients were followed-up regularly for the next 18 months.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
115

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2012

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

March 29, 2014

Completed
17 days until next milestone

First Posted

Study publicly available on registry

April 15, 2014

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
Last Updated

April 15, 2014

Status Verified

April 1, 2014

Enrollment Period

2.8 years

First QC Date

March 29, 2014

Last Update Submit

April 14, 2014

Conditions

Keywords

AmblyopiaStrabismusOcclusion therapyVisual improvement

Outcome Measures

Primary Outcomes (1)

  • Visual Acuity improvement

    Full-time occlusion therapy of good eye was performed for 2-3 months while closely monitoring the vision of both the good and the amblyopic eye. Vision was assessed by EDTRS Charts as well as Snellen's Chart.

    3 months

Secondary Outcomes (1)

  • improvement in stereopsis

    1 year

Other Outcomes (1)

  • Does the patched good eye develop occlusion amblyopia

    3 months

Study Arms (1)

Visual improvement

EXPERIMENTAL

To see how efficiently visual improvement occurs by Full-time Occlusion therapy with an eye patch in severe amblyopia.

Device: Occlusion therapy by Eye PatchDevice: Occlusion therapy

Interventions

The good eye was occluded by a stick-on eye patch to stimulate the amblyopic eye and its neural connections to learn to see again.

Visual improvement

To see how much improvement in visual acuity occurs by full-time occlusion therapy.

Also known as: eye patch (commercially pre-packed)
Visual improvement

Eligibility Criteria

Age3 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • a visual acuity of 6/60 or 0.1-0.2 ETDRS in one eye and 6/6 or 1.0 ETDRS in the good eye
  • strabismic amblyopia
  • patients of any age were included.

You may not qualify if:

  • structural damage to the eye (organic amblyopia)
  • ametropic amblyopia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mughal Eye Trust Hospital

Lahore, Punjab Province, 54770, Pakistan

Location

MeSH Terms

Conditions

AmblyopiaStrabismus

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesVision DisordersSensation DisordersNeurologic ManifestationsEye DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsOcular Motility DisordersCranial Nerve Diseases

Study Officials

  • Sameera Irfan, FRCS

    Mughal Eye Trust Hospital, Lahore, Pakistan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant Ophthalmologist

Study Record Dates

First Submitted

March 29, 2014

First Posted

April 15, 2014

Study Start

January 1, 2010

Primary Completion

October 1, 2012

Study Completion

June 1, 2014

Last Updated

April 15, 2014

Record last verified: 2014-04

Locations